Alper Ergin

412 total citations
26 papers, 307 citations indexed

About

Alper Ergin is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Alper Ergin has authored 26 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Infectious Diseases and 9 papers in Molecular Medicine. Recurrent topics in Alper Ergin's work include Antibiotic Resistance in Bacteria (9 papers), Pneumonia and Respiratory Infections (6 papers) and Streptococcal Infections and Treatments (5 papers). Alper Ergin is often cited by papers focused on Antibiotic Resistance in Bacteria (9 papers), Pneumonia and Respiratory Infections (6 papers) and Streptococcal Infections and Treatments (5 papers). Alper Ergin collaborates with scholars based in Türkiye. Alper Ergin's co-authors include Özgen Köseoğlu Eser, Gülşen Hasçelik, Rıza Durmaz, Serpil Erciş, İrem Dinçer, Tanıl Kocagöz, S. Arıkan, Gülşen Özkaya Şahin, Ömrüm Uzun and Simel Ayyıldız and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents and Current Microbiology.

In The Last Decade

Alper Ergin

26 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alper Ergin Türkiye 11 151 105 77 62 55 26 307
Edward F. Keen United States 6 176 1.2× 140 1.3× 61 0.8× 66 1.1× 112 2.0× 6 400
Tianshui Niu China 10 141 0.9× 124 1.2× 71 0.9× 47 0.8× 47 0.9× 17 270
Mojtaba Anvarinejad Iran 11 153 1.0× 125 1.2× 57 0.7× 119 1.9× 60 1.1× 26 392
Elisoa Ratsima Madagascar 10 167 1.1× 171 1.6× 58 0.8× 94 1.5× 48 0.9× 15 367
Yoko Takayama Japan 9 128 0.8× 100 1.0× 107 1.4× 80 1.3× 30 0.5× 42 348
Latifa Noussair France 11 209 1.4× 129 1.2× 121 1.6× 90 1.5× 72 1.3× 27 433
Ya‐Fen Tang Taiwan 10 195 1.3× 143 1.4× 56 0.7× 75 1.2× 50 0.9× 14 363
Anusha Rohit India 11 159 1.1× 64 0.6× 67 0.9× 53 0.9× 54 1.0× 48 328
Özgen Köseoğlu Eser Türkiye 9 184 1.2× 66 0.6× 39 0.5× 80 1.3× 43 0.8× 24 267
Margarida Pinto Portugal 10 166 1.1× 54 0.5× 47 0.6× 82 1.3× 46 0.8× 28 320

Countries citing papers authored by Alper Ergin

Since Specialization
Citations

This map shows the geographic impact of Alper Ergin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alper Ergin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alper Ergin more than expected).

Fields of papers citing papers by Alper Ergin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alper Ergin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alper Ergin. The network helps show where Alper Ergin may publish in the future.

Co-authorship network of co-authors of Alper Ergin

This figure shows the co-authorship network connecting the top 25 collaborators of Alper Ergin. A scholar is included among the top collaborators of Alper Ergin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alper Ergin. Alper Ergin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alp, Alpaslan, et al.. (2022). [Evaluation of the Respiratory Viral Panel PCR Test Results Before and After COVID-19 Pandemic].. PubMed. 56(4). 667–681. 4 indexed citations
2.
Ergin, Alper, et al.. (2020). Çok İlaca Dirençli İnvaziv Acinetobacter baumannii İzolatlarında Biyofilm ve Biyofilm İlişkili Virülans Genlerinin Varlığı. Mikrobiyoloji Bulteni. 54(1). 40–49. 6 indexed citations
3.
4.
Eser, Özgen Köseoğlu, Alper Ergin, & Gülşen Hasçelik. (2015). Antimicrobial Activity of Copper Alloys Against Invasive Multidrug-Resistant Nosocomial Pathogens. Current Microbiology. 71(2). 291–295. 22 indexed citations
5.
Eser, Özgen Köseoğlu, et al.. (2014). İnvazif Enfeksiyonlara Neden Olan GSBL Pozitif Enterobacteriaceae İzolatlarında Karbapenem Direnci*. Mikrobiyoloji Bulteni. 48(1). 59–69. 10 indexed citations
6.
Şahin, Cem, Alper Ergin, Simel Ayyıldız, Erdal Coşgun, & Gülay Uzun. (2013). Effect of biofilm formation, and biocorrosion on denture base fractures. The Journal of Advanced Prosthodontics. 5(2). 140–140. 9 indexed citations
7.
Ergin, Alper, Gülşen Hasçelik, & Özgen Köseoğlu Eser. (2012). Molecular characterization of oxacillinases and genotyping of invasive Acinetobacter baumannii isolates using repetitive extragenic palindromic sequence-based polymerase chain reaction in Ankara between 2004 and 2010. Scandinavian Journal of Infectious Diseases. 45(1). 26–31. 22 indexed citations
8.
Eser, Özgen Köseoğlu, Şehnaz Alp, Alper Ergin, et al.. (2012). [Comparison of culture and real-time PCR methods in the detection of Streptococcus pneumoniae and Haemophilus influenzae in acute otitis media effusion specimens].. PubMed. 46(4). 676–81. 3 indexed citations
9.
Ergin, Alper. (2010). [Classical and new approaches in laboratory diagnosis of viridans streptococci].. PubMed. 44(3). 495–503. 3 indexed citations
10.
Eser, Özgen Köseoğlu, Alper Ergin, & Gülşen Hasçelik. (2009). [Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].. PubMed. 43(3). 383–90. 13 indexed citations
11.
Eser, Özgen Köseoğlu & Alper Ergin. (2009). ERİŞKİN HASTALARDAN İZOLE EDİLEN ACINETOBACTER TÜRLERİNDE ANTİMİKROBİYAL DİRENÇ VE METALLO-BETA-LAKTAMAZ VARLIĞI* ANTIMICROBIAL RESISTANCE AND EXISTENCE OF METALLO-BETA-LACTAMASE IN ACINETOBACTER SPECIES ISOLATED FROM ADULT PATIENTS. 4 indexed citations
12.
Ergin, Alper, et al.. (2008). In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp.. PubMed. 31(4). 535–42. 13 indexed citations
13.
Erciş, Serpil, Alper Ergin, Gülşen Özkaya Şahin, Gülşen Hasçelik, & Ömrüm Uzun. (2006). Validation of Urinary Antigen Test for <i>Streptococcus pneumoniae</i> in Patients with Pneumococcal Pneumonia. Japanese Journal of Infectious Diseases. 59(6). 388–390. 10 indexed citations
14.
Ergin, Alper, Serpil Erciş, & Gülşen Hasçelik. (2005). Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures. Journal of Antimicrobial Chemotherapy. 57(1). 139–141. 17 indexed citations
15.
Erciş, Serpil, Alper Ergin, & Gülşen Hasçelik. (2005). [Six years evaluation of Clostridium difficile associated diarrhea].. PubMed. 38(1-2). 45–50. 1 indexed citations
16.
Dinçer, İrem, Alper Ergin, & Tanıl Kocagöz. (2004). The vitro efficacy of β-lactam and β-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis. International Journal of Antimicrobial Agents. 23(4). 408–411. 27 indexed citations
17.
Ergin, Alper, et al.. (2004). Evaluation of Restriction Endonuclease Analysis of BRO Beta-lactamases in Clinical and Carrier Isolates of Moraxella catarrhalis. Scandinavian Journal of Infectious Diseases. 36(6-7). 431–434. 8 indexed citations
18.
Ergin, Alper. (2003). In vitro susceptibility, tolerance and MLS resistance phenotypes of Group C and Group G streptococci isolated in Turkey between 1995 and 2002. International Journal of Antimicrobial Agents. 22(2). 160–163. 8 indexed citations
19.
20.
Ensarı, Serdar, et al.. (1995). The Use of Molded Tympanic Heterograft (Lamb Peritoneum). Ear Nose & Throat Journal. 74(7). 487–489. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward F. Keen Breakdown of academic impact, for papers by Tianshui Niu Breakdown of academic impact, for papers by Mojtaba Anvarinejad Breakdown of academic impact, for papers by Elisoa Ratsima Breakdown of academic impact, for papers by Yoko Takayama Breakdown of academic impact, for papers by Latifa Noussair Breakdown of academic impact, for papers by Ya‐Fen Tang Breakdown of academic impact, for papers by Anusha Rohit Breakdown of academic impact, for papers by Özgen Köseoğlu Eser Breakdown of academic impact, for papers by Margarida Pinto
Rankless by CCL
2026